You will be shown inclusion or exclusion criteria for a clinical trial. Given these criteria, your task is to extract all unique entities of the following types: ["Observation", "Condition", "Procedure", "Drug", "Temporal", "Multiplier", "Qualifier", "Negation", "ReferencePoint", "Scope", "Value", "Mood", "Device", "Visit", "Measurement", "Person"].

Please return the output as a JSON object of the format: {"Condition" : ["breast cancer", ...], "Device" : ["ports", ...], "Drug" : ["Atenolol", ...], "Measurement" : ["blood pressure", ...], "Mood" : ["suspected", ...], "Multiplier" : ["more than two", ...], "Negation" : ["no", ...], "Observation" : ["history", ...], "Person" : ["male", ...], "Procedure" : ["surgery", ...], "Qualifier" : ["severe", ...], "ReferencePoint" : ["enrollment", ...], "Scope" : ["infection", ...], "Temporal" : ["one day", ...], "Value" : ["50%", ...], "Visit" : ["ICU", ...]}. The keys should be entity types and values should be lists of extracted entities belonging to the corresponding type. If you cannot find entities belonging to a specific type, the value should be [].

Only output the JSON object and do not include any additional text.

Abstract:

1. Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy as judged by the investigator. 
2. Recent (< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery. 
3. Ongoing pregnancy. 
4. Severe hypoglycemic episode within 1 month of screening. 
5. Agents affecting gastric emptying (Motilium®, Prandase®, Victoza®, Byetta® and Symlin®) as well as oral anti-diabetic agents (Metformin, SGLT-2 inhibitors and DPP-4 inhibitors) if not at a stable dose for 3 months. Otherwise, these medications are acceptable and will be kept stable during the entire protocol. 
6. Oral steroids unless patients present a low stable dose (e.g. 10 mg or less of prednisone per day or physiological doses, less than 35 mg/day, of hydrocortisone Cortef®). Inhale steroids at stable dose in the last month are acceptable. 
7. Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator (e.g. unstable psychiatric condition). 
8. Failure to comply with team's recommendations (e.g. not willing to change pump parameters, follow algorithm's suggestions, etc). 
9. Living or planned travel outside Montreal (> 1h of driving) area during closed-loop procedures.
{"Condition": ["cardiac surgery", "severe proliferative retinopathy", "pregnancy", "nephropathy", "microvascular complications", "neuropathy", "acute macrovascular event", "psychiatric condition", "Other medical illness", "gastroparesis", "hypoglycemic episode", "acute coronary syndrome"], "Device": [], "Drug": ["Metformin", "Inhale steroids", "Motilium", "oral anti-diabetic agents", "Victoza", "prednisone", "Agents affecting gastric emptying", "DPP-4 inhibitors", "Oral steroids", "Byetta", "Prandase", "Cortef", "SGLT-2 inhibitors", "hydrocortisone", "Symlin"], "Measurement": ["estimated glomerular filtration rate"], "Mood": [], "Multiplier": ["physiological doses", "less than 35 mg/day", "10 mg or less per day"], "Negation": ["unless", "not"], "Observation": [], "Person": [], "Procedure": ["closed-loop procedures"], "Qualifier": ["stable dose", "as judged by the investigator", "serious", "Severe", "unstable", "low dose"], "ReferencePoint": ["closed-loop procedures"], "Scope": ["10 mg or less of prednisone per day or physiological doses, less than 35 mg/day, of hydrocortisone Cortef", "nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy", "Motilium\u00ae, Prandase\u00ae, Victoza\u00ae, Byetta\u00ae and Symlin\u00ae", "Other serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator", "acute coronary syndrome or cardiac surgery", "stable dose for 3 months", "Metformin, SGLT-2 inhibitors and DPP-4 inhibitors"], "Temporal": ["Recent", "\u003c 3 months", "during closed-loop procedures", "within 1 month of screening", "for 3 months", "in the last month", "Ongoing"], "Value": ["below 40 ml/min"], "Visit": []}